00

Jiangsu Sihuan Bioengineering Co LtdSHE 000518 Stock Report

Last reporting period 30 Jun, 2023

Updated 31 Oct, 2024

Last price

Market cap $B

0.308

Micro

Exchange

XSHE - Shenzhen Stock Exchange

000518.SZ Stock Analysis

00

Uncovered

Jiangsu Sihuan Bioengineering Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-12/100

Low score

Market cap $B

0.308

Dividend yield

Shares outstanding

1 029.56 B

Jiangsu Sihuan Bioengineering Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. The company is headquartered in Wuxi, Jiangsu and currently employs 254 full-time employees. The Company’s main products include interleukin, erythropoietin (EPO), granulocyte colony-stimulating factor (G-CSF), tablets, bulk drugs, infusion glass bottles, soft bag infusion, syrup and healthcare products, among others. The firm is also engaged in landscape engineering, maintenance projects, the sale of nursery stocks and other businesses. The firm distributes its products in domestic market and to overseas markets.

View Section: Eyestock Rating